← FDA DRUG APPROVALS

FDA ANDA · ANDA078086

DEFEROXAMINE MESYLATE

Sponsor: HIKMA

APPLICATION
ANDA078086
TYPE
ANDA
ORIGINAL APPROVAL
2007-05-30
LATEST ACTION
2011-05-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DEFEROXAMINE MESYLATEDiscontinued
DEFEROXAMINE MESYLATE 500MG/VIAL · INJECTABLE · INJECTION
DEFEROXAMINE MESYLATEDiscontinued
DEFEROXAMINE MESYLATE 2GM/VIAL · INJECTABLE · INJECTION

Approval history

2011-05-26Labeling · Supplement 5AP
2009-12-03Labeling · Supplement 1AP
2007-05-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →